We are advising Cross Country Healthcare on the transaction

Davis Polk is advising Cross Country Healthcare, Inc. on its sale to Knox Lane. Under the terms of the transaction, Knox Lane will acquire all outstanding shares of Cross Country Healthcare common stock for $13.25 per share in an all-cash transaction valued at $437 million. The transaction is expected to close in the third quarter of 2026, subject to customary closing conditions and regulatory approvals.

Cross Country Healthcare is a technology-driven healthcare workforce solutions company, delivering an AI-powered digital platform and advisory services backed by 40 years of healthcare labor expertise to help health systems optimize and sustain their entire labor ecosystem.Based in San Francisco, Knox Lane is a growth-oriented investment firm comprised of a team of accomplished investors and operators with a shared work history and a strong track record of working with leading companies to accelerate transformational growth.

The Davis Polk corporate team includes partners H. Oliver Smith and Brian Wolfe and associates David A. Friedman and Sophie Liao. Partner Adam Kaminsky is providing executive compensation advice. Partner Nathaniel L. Asker and counsel Gregory S. Morrison are providing antitrust and competition advice. Partner William A. Curran is providing tax advice. Partner Pritesh P. Shah is providing intellectual property advice. Members of the Davis Polk team are based in the New York and Washington DC offices.

Copy link to share post